103 related articles for article (PubMed ID: 36706163)
1. Immune Checkpoint Inhibitors in Solid Organ Transplant Recipients With Advanced Skin Cancers-Emerging Strategies for Clinical Management.
Ferrándiz-Pulido C; Leiter U; Harwood C; Proby CM; Guthoff M; Scheel CH; Westhoff TH; Bouwes Bavinck JN; Meyer T; Nägeli MC; Del Marmol V; Lebbé C; Geusau A
Transplantation; 2023 Jul; 107(7):1452-1462. PubMed ID: 36706163
[TBL] [Abstract][Full Text] [Related]
2. A Pilot Study of Checkpoint Inhibitors in Solid Organ Transplant Recipients with Metastatic Cutaneous Squamous Cell Carcinoma.
Tsung I; Worden FP; Fontana RJ
Oncologist; 2021 Feb; 26(2):133-138. PubMed ID: 32969143
[TBL] [Abstract][Full Text] [Related]
3. Immune checkpoint inhibitors in kidney transplantation.
Alzahrani N; Al Jurdi A; Riella LV
Curr Opin Organ Transplant; 2023 Feb; 28(1):46-54. PubMed ID: 36579684
[TBL] [Abstract][Full Text] [Related]
4. Immunity against Non-Melanoma Skin Cancer and the Effect of Immunosuppressive Medication on Non-Melanoma Skin Cancer Risk in Solid Organ Transplant Recipients.
Bakker D; Bakker WJ; Bekkenk MW; Luiten RM
Cells; 2023 Oct; 12(20):. PubMed ID: 37887285
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous squamous cell carcinoma in the organ transplant recipient.
Bibee K; Swartz A; Sridharan S; Kurten CHL; Wessel CB; Skinner H; Zandberg DP
Oral Oncol; 2020 Apr; 103():104562. PubMed ID: 32065978
[TBL] [Abstract][Full Text] [Related]
6. Acute renal transplant rejection following nivolumab therapy for metastatic melanoma.
Tan B; Baxter M; Casasola R
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33558380
[TBL] [Abstract][Full Text] [Related]
7. Risk of Rare Cancers Among Solid Organ Transplant Recipients.
D'Arcy ME; Castenson D; Lynch CF; Kahn AR; Morton LM; Shiels MS; Pfeiffer RM; Engels EA
J Natl Cancer Inst; 2021 Feb; 113(2):199-207. PubMed ID: 32462187
[TBL] [Abstract][Full Text] [Related]
8. Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma.
Hanna GJ; Dharanesswaran H; Giobbie-Hurder A; Harran JJ; Liao Z; Pai L; Tchekmedyian V; Ruiz ES; Waldman AH; Schmults CD; Riella LV; Lizotte P; Paweletz CP; Chandraker AK; Murakami N; Silk AW
J Clin Oncol; 2024 Mar; 42(9):1021-1030. PubMed ID: 38252908
[TBL] [Abstract][Full Text] [Related]
9. Updates in Skin Cancer in Transplant Recipients and Immunosuppressed Patients: Review of the 2022-2023 Scientific Symposium of the International Immunosuppression and Transplant Skin Cancer Collaborative.
Pisano C; Leitenberger JJ; Pugliano-Mauro M; Carroll BT
Transpl Int; 2024; 37():12387. PubMed ID: 38562207
[TBL] [Abstract][Full Text] [Related]
10. Immune checkpoint blockers in solid organ transplant recipients and cancer: the INNOVATED cohort.
Remon J; Auclin E; Zubiri L; Schneider S; Rodriguez-Abreu D; Minatta N; Gautschi O; Aboubakar F; Muñoz-Couselo E; Pierret T; Rothschild SI; Cortiula F; Reynolds KL; Thibault C; Gavralidis A; Blais N; Barlesi F; Planchard D; Besse BMD
ESMO Open; 2024 May; 9(5):103004. PubMed ID: 38653155
[TBL] [Abstract][Full Text] [Related]
11. Fine-tuning tumor- and allo-immunity: advances in the use of immune checkpoint inhibitors in kidney transplant recipients.
Van Meerhaeghe T; Murakami N; Le Moine A; Brouard S; Sprangers B; Degauque N
Clin Kidney J; 2024 Apr; 17(4):sfae061. PubMed ID: 38606169
[TBL] [Abstract][Full Text] [Related]
12. Durable complete response to early immunotherapy discontinuation in a kidney transplant recipient with advanced cutaneous squamous cell carcinoma: A case report and review of literature.
Lu Z; Afzal M; Shirai K
Transpl Immunol; 2023 Dec; 81():101932. PubMed ID: 37734447
[TBL] [Abstract][Full Text] [Related]
13. Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors.
Spillane S; Baxi S; Torres AZ; Lenis D; Freedman AN; Mariotto AB; Sharon E
Oncologist; 2020 Nov; 25(11):e1753-e1762. PubMed ID: 33094874
[TBL] [Abstract][Full Text] [Related]
14. Cancer Screening in Solid Organ Transplant Recipients: A Focus on Screening Liver, Lung, and Kidney Recipients for Cancers Related to the Transplanted Organ.
Dharia A; Boulet J; Sridhar VS; Kitchlu A
Transplantation; 2022 Jan; 106(1):e64-e65. PubMed ID: 33795594
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Outcomes of Cutaneous Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Retrospective Comparative Cohort Study.
Salido-Vallejo R; Escribano-Castillo L; Antoñanzas J; Roldán-Córdoba C; Velez A; Aguado-Gil L
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137687
[TBL] [Abstract][Full Text] [Related]
16. External Validation of the Skin and UV Neoplasia Transplant Risk Assessment Calculator (SUNTRAC) in a Large European Solid Organ Transplant Recipient Cohort.
Gómez-Tomás Á; Bouwes Bavinck JN; Genders R; González-Cruz C; de Jong E; Arron S; García-Patos V; Ferrándiz-Pulido C
JAMA Dermatol; 2023 Jan; 159(1):29-36. PubMed ID: 36416811
[TBL] [Abstract][Full Text] [Related]
17. Rapid Life-Saving Response to Anti-PD-1 in a Solid Organ Transplant Recipient With Metastatic Cutaneous Squamous Cell Carcinoma: A Case Report and Review.
Antonelli JP; Quach M; Mahajan A; Pleva J; Ma VT
J Immunother; 2024 Mar; ():. PubMed ID: 38532708
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy use outside clinical trial populations: never say never?
Rzeniewicz K; Larkin J; Menzies AM; Turajlic S
Ann Oncol; 2021 Jul; 32(7):866-880. PubMed ID: 33771665
[TBL] [Abstract][Full Text] [Related]
19. First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO trial).
Spreafico A; Heirali AA; Araujo DV; Tan TJ; Oliva M; Schneeberger PHH; Chen B; Wong MK; Stayner LA; Hansen AR; Saibil SD; Wang BX; Cochrane K; Sherriff K; Allen-Vercoe E; Xu W; Siu LL; Coburn B
Ann Oncol; 2023 Jun; 34(6):520-530. PubMed ID: 36863483
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous squamous cell carcinoma tumor accrual rates in immunosuppressed patients with autoimmune and inflammatory conditions: A retrospective cohort study.
Granger EE; Groover M; Harwood C; Proby CM; Karn E; Murad F; Schmults CD; Ruiz ES
J Am Acad Dermatol; 2024 Apr; 90(4):731-738. PubMed ID: 38043592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
